Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Leah L. Zullig"'
Autor:
Lavanya Vasudevan, Kristin Schroeder, Yadurshini Raveendran, Kunal Goel, Christina Makarushka, Nestory Masalu, Leah L. Zullig
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background In high-income countries (HICs), increased rates of survival among pediatric cancer patients are achieved through the use of protocol-driven treatment. Compared to HICs, differences in infrastructure, supportive care, and human re
Externí odkaz:
https://doaj.org/article/95569d174b474b7b90d1bb650392f308
Autor:
Leah L. Zullig, Yadurshini Raveendran, Lavanya Vasudevan, Kunal Goel, Christina Makarushka, Kristin Schroeder, Nestory Masalu
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-14 (2020)
BMC Cancer
BMC Cancer
Background In high-income countries (HICs), increased rates of survival among pediatric cancer patients are achieved through the use of protocol-driven treatment. Compared to HICs, differences in infrastructure, supportive care, and human resources,
Autor:
Patricia A. Ganz, JT Kolimaga, John Z. Ayanian, Steven C. Grambow, Jennifer Malin, Mona N. Fouad, S. Yousuf Zafar, David H. Abbott, Leah L. Zullig, Paul J. Catalano, Dee W. West, Katherine L. Kahn, Jane C. Weeks, Robert B. Wallace, Dawn Provenzale, Deborah Schrag
Publikováno v:
BMC Cancer, Vol 11, Iss 1, p 354 (2011)
Zafar, S Yousuf; Malin, Jennifer L; Grambow, Steven C; Abbott, David H; Schrag, Deborah; Kolimaga, Jane T; et al.(2011). Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study. BMC Cancer, 11(1), 354. doi: http://dx.doi.org/10.1186/1471-2407-11-354. Retrieved from: http://www.escholarship.org/uc/item/2z325288
BMC Cancer
Zafar, S Yousuf; Malin, Jennifer L; Grambow, Steven C; Abbott, David H; Schrag, Deborah; Kolimaga, Jane T; et al.(2011). Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study. BMC Cancer, 11(1), 354. doi: http://dx.doi.org/10.1186/1471-2407-11-354. Retrieved from: http://www.escholarship.org/uc/item/2z325288
BMC Cancer
Background We describe early dissemination patterns for first-line bevacizumab given for metastatic colorectal cancer treatment. Methods We analyzed patient surveys and medical records for a population-based cohort with metastatic colorectal cancer t
Autor:
Leah L. Zullig, David H. Abbott, Jennifer Marcello, James E. Herndon, Amy P. Abernethy, Dawn Provenzale, S. Yousuf Zafar, Steven C. Grambow, Meenal B. Patwardhan, JT Kolimaga, Krista Rowe
Publikováno v:
BMC Cancer, Vol 8, Iss 1, p 345 (2008)
BMC Cancer
BMC Cancer
© 2008 Zafar et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and r